Patient Leaflet Updated 18-Mar-2024 | Aspire Pharma Ltd
Ibuprofen Seven Plus Pain Relief 200mg/5ml oral suspension
Ibuprofen Seven Plus Pain Relief 200mg/5ml oral suspension
Ibuprofen
The name of your medicine is Ibuprofen Seven Plus Pain Relief 200mg/5ml oral suspension which will be referred to as ‘Ibuprofen oral suspension’ throughout this leaflet.
This medicine is available without prescription, but you still need to give this medicine carefully to get the best results from it. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.
1. What Ibuprofen oral suspension is and what it is used for
2. What you need to know before you give Ibuprofen oral suspension
3. How to give Ibuprofen oral suspension
4. Possible side effects
5. How to store Ibuprofen oral suspension
6. Contents of the pack and other information
This medicine contains ibuprofen as the active ingredient. Each 5ml of oral suspension contains 200mg of ibuprofen. This is twice the strength of normal ibuprofen suspension and you should be careful that you use the correct dose.
Ibuprofen belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is given to children aged 7-12 years as a painkiller for relief of:
This medicine should not be used for more than 3 days.
This medicine is suitable for the majority of people, but certain people should not use it. Talk to your pharmacist or doctor if you are at all unsure or if you have an infection (please see heading ‘Infections’ below).
Signs of an allergic reaction to this medicine, including breathing problems, swelling of the face and neck region (angioedema), chest pain have been reported with ibuprofen. Stop immediately Ibuprofen oral suspension and contact immediately your doctor or medical emergencies if you notice any of these signs.
You should discuss your child’s treatment with your doctor or pharmacist before giving this medicine if your child:
If you are taking Ibuprofen oral suspension for longer than the recommended time or at higher than recommended doses you are at risk of serious harm. These include serious harms to the stomach/gut and kidneys, as well as very low levels of potassium in your blood. These can be fatal (see section 4).
Serious skin reactions including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP) have been reported in association with ibuprofen treatment. Stop using Ibuprofen oral suspension and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
Do not exceed the recommended dose or duration of treatment.
There is a risk of renal (kidney) impairment in dehydrated children.
Drinking alcohol while taking ibuprofen may increase the risk of certain side effects.
Tell your doctor or pharmacist if your child is taking, has recently taken or might take any other medicines, including medicines obtained without a prescription.
Ibuprofen may affect or be affected by some medicines.
For example:
Some other medicines may also affect or be affected by the treatment of ibuprofen. You should therefore always seek the advice of your child’s doctor or pharmacist before you give ibuprofen with other medicines.
This medicine contains maltitol liquid and sodium
The following warnings are less likely to apply to children but should be considered before giving this medicine.
Pregnancy
Tell your doctor if you become pregnant whilst taking this medicine.
Ibuprofen belongs to a group of medicines which may impair fertility in women. This is reversible on stopping the medicine. It is unlikely that this medicine, used occasionally will affect your chances of becoming pregnant. However, tell your doctor before taking this medicine if you have problems becoming pregnant.
You should only take this product on a doctor’s advice during the first 6 months of pregnancy.
DO NOT take Ibuprofen oral suspension if you are in the last 3 months of pregnancy as it could harm your unborn child or cause problems at delivery. It can cause kidney and heart problems in your unborn baby. It may affect your and your baby’s tendency to bleed and cause labour to be later or longer than expected. You should not take Ibuprofen oral suspension during the first 6 months of pregnancy unless absolutely necessary and advised by your doctor. If you need treatment during this period or while you are trying to get pregnant, the lowest dose for the shortest time possible should be used. If taken for more than a few days from 20 weeks of pregnancy onward, Ibuprofen oral suspension can cause kidney problems in your unborn baby that may lead to low levels of amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the heart of the baby. If you need treatment for longer than a few days, your doctor may recommend additional monitoring.
Ibuprofen oral suspension may hide signs of infections such as fever and pain. It is therefore possible that Ibuprofen oral suspension may delay appropriate treatment of infection, which may lead to an increased risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chicken pox. If you take this medicine while you have an infection and your symptoms of the infection persist or worsen, consult a doctor without delay.
This product is twice the strength of normal ibuprofen suspension and you should be careful that you use the correct dose.
Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or a pharmacist if you are not sure.
The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Always shake the bottle vigorously before use.
To remove the cap, push it down and turn it anti-clockwise. There is a 5ml oral syringe (graduated in 0.25ml steps), which should be used to give the medicine.
The recommended dose is:
Age How much
Under seven years Do not use
Seven - nine years One 5ml dose up to three times in 24 hours
Ten - twelve years One 5ml dose and one 2.5ml dose up to three times in 24 hours
Warning: Do not exceed the stated dose.
This product is intended for short term use only. You must talk to your doctor or pharmacist if your child does not get better or feels worse after three days.
If you have given more medicine than you should, or if children have taken this medicine by accident always contact a doctor or nearest hospital to get an opinion of the risk and advice on action to be taken.
The symptoms of an overdose can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, coma, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.
If you forget to give a dose, give it as soon as you remember, unless it is almost time for the next dose. Do not give a double dose to make up for the missed dose.
For oral use only.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side-effects, although not everybody gets them. Tell your doctor or pharmacist if you notice any of the following:
This medicine, especially when taken at higher than recommended doses or for a prolonged period of time, can cause damage to your kidneys and affect them removing acids properly from your blood into the urine (renal tubular acidosis). It can also cause very low levels of potassium in your blood (see section 2). This is a very serious condition and will require immediate treatment. Signs and symptoms include muscle weakness and light headedness.
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Side effects for which the frequency cannot be estimated from available data:
Medicines such as Ibuprofen oral suspension may be associated with a small increased risk of heart attack (‘myocardial infarction’) or stroke. See section 2 ‘Other warnings’.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store). By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and bottle after ‘EXP’. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Once opened, this medicine is stable at room temperature for 6 months.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is ibuprofen.
5ml oral suspension contains 200mg ibuprofen.
The other ingredients are:
Sodium benzoate (E211), citric acid anhydrous, sodium citrate, saccharin sodium, sodium chloride, hypromellose, xanthan gum, maltitol liquid, glycerol (E422), thaumatin (E957), strawberry flavour (natural flavouring preparations, maize maltodextrin, triethyl citrate (E-1505), propylene glycol (E-1520) and benzyl alcohol), purified water.
Ibuprofen oral suspension is a white or off-white viscous suspension.
It is available in bottles of 30ml and 100ml with a child-resistant closure.
Not all pack-sizes may be marketed.
For accurate dosing a polypropylene oral syringe for oral administration, graduated in 0.25ml steps up to 5ml, is included in the pack.
Marketing Authorisation Holder
Manufacturer
Or
Or
Or
This leaflet was last revised in 01/2024
1010459-P13.2E
PR-4011.0324
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
+44 (0)1730 231148
http://www.aspirepharma.co.uk
+44 (0)1730 231148
+44 (0)1730 231148